Brief Report: Association of Rheumatoid Factor and Anti-Citrullinated Protein Antibody Positivity With Better Effectiveness of Abatacept: Results From the Pan-European Registry Analysis. (Q40055726)

From Wikidata

Jump to navigation Jump to search

scientific article published on 27 January 2016

Language	Label	Description	Also known as
English	Brief Report: Association of Rheumatoid Factor and Anti-Citrullinated Protein Antibody Positivity With Better Effectiveness of Abatacept: Results From the Pan-European Registry Analysis.	scientific article published on 27 January 2016

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26815727%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Brief Report: Association of Rheumatoid Factor and Anti-Citrullinated Protein Antibody Positivity With Better Effectiveness of Abatacept: Results From the Pan-European Registry Analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26815727%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Florenzo Iannone

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26815727%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

María Victoria Hernández

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26815727%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26815727%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26815727%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Merete Lund Hetland

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26815727%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

J E Gottenberg

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26815727%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

D S Courvoisier

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26815727%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

E Lie

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26815727%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

C Turesson

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26815727%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

X Mariette

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26815727%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

A Finckh

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26815727%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

publication date

1 June 2016

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26815727%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Arthritis & Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26815727%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

68

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26815727%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26815727%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1346-1352

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26815727%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Anti-CCP antibodies: the past, the present and the future

1 reference

https://api.crossref.org/works/10.1002%2FART.39595

21 January 2018

Redefining the HLA and RA association: to be or not to be anti-CCP positive.

1 reference

https://api.crossref.org/works/10.1002%2FART.39595

21 January 2018

Non-HLA genes PTPN22, CDK6 and PADI4 are associated with specific autoantibodies in HLA-defined subgroups of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.39595

21 January 2018

Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.39595

21 January 2018

Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries

1 reference

https://api.crossref.org/works/10.1002%2FART.39595

21 January 2018

Longterm followup of rituximab therapy in patients with rheumatoid arthritis: results from the Belgian MabThera in Rheumatoid Arthritis registry

1 reference

https://api.crossref.org/works/10.1002%2FART.39595

21 January 2018

Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the 'Orencia and Rheumatoid Arthritis' registry

1 reference

https://api.crossref.org/works/10.1002%2FART.39595

21 January 2018

Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study

1 reference

https://api.crossref.org/works/10.1002%2FART.39595

21 January 2018

A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries

1 reference

https://api.crossref.org/works/10.1002%2FART.39595

21 January 2018

DANBIO--powerful research database and electronic patient record

1 reference

https://api.crossref.org/works/10.1002%2FART.39595

21 January 2018

Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumati

1 reference

https://api.crossref.org/works/10.1002%2FART.39595

21 January 2018

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.39595

21 January 2018

The status of rheumatoid factor and anti-cyclic citrullinated peptide antibody are not associated with the effect of anti-TNFα agent treatment in patients with rheumatoid arthritis: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1002%2FART.39595

21 January 2018

CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients

1 reference

https://api.crossref.org/works/10.1002%2FART.39595

21 January 2018

Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging pilot study

1 reference

https://api.crossref.org/works/10.1002%2FART.39595

21 January 2018

Abatacept reduces levels of switched memory B cells, autoantibodies, and immunoglobulins in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.39595

21 January 2018

Abatacept Limits Breach of Self-Tolerance in a Murine Model of Arthritis via Effects on the Generation of T Follicular Helper Cells

1 reference

https://api.crossref.org/works/10.1002%2FART.39595

21 January 2018

Identifiers

10.1002/ART.39595

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26815727%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26815727%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40055726&oldid=1482939394"